AIDS

New Pandemic Agreement: Pharma Wins, Developing World Loses, says AHF Global Public Health Institute

Retrieved on: 
Friday, April 26, 2024
COVID-19, Public Policy, Other Policy Issues, Healthcare Reform, Pharmaceutical, Social Activism, Communications, General Health, Philanthropy, Advocacy Group Opinion, Infectious Diseases, Government, Foundation, AIDS, Health, United Nations, Public, University, IHR, PABS, Language, WHO, Community of practice, Learning, Pandemic, World Health Organization, INB, Policy, Infection, Intergovernmental, Conference, Research, Vaccine, Hoarding, Literature, International Health Regulations, AIDS Healthcare Foundation, Panel, Global health, Secretariat, AHF, United Nations General Assembly, Lancet, Letter, Pharmaceutical industry

As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024, Proposal for the WHO Pandemic Agreement.

Key Points: 
  • As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024, Proposal for the WHO Pandemic Agreement.
  • In addition to the GPMB and the IPPPR, the Panel for a Global Public Health Convention and Spark Street Advisors have also emphasized the critical need for independent monitoring.
  • Empty handshakes in Geneva will not prevent another global health disaster, nor will it keep countries from trampling over each other when the next pandemic comes.
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .

Latin America CDC a Must, say Public Health Leaders and AHF

Retrieved on: 
Friday, April 26, 2024
COVID-19, Infectious Diseases, Hospitals, Hispanic, Other Health, Managed Care, Health, Consumer, General Health, Mark R. Dybul, Public, University, Pandemic, AIDS, Safety, Public health, World Health Organization, Policy, CDC, Dengue fever, AH1N1, Infection, LATAM, Research, Vaccine, Cayetano Heredia University, Emergency, AIDS Healthcare Foundation, Acquisition, Data collection, Private sector, Death, Faculty, AHF, Lancet

This new agency would seek to strengthen regional resilience against future health crises through collaboration and resource optimization among nations.

Key Points: 
  • This new agency would seek to strengthen regional resilience against future health crises through collaboration and resource optimization among nations.
  • Patricia J. Garcia, former health minister of Peru, principal professor of the Faculty of Public Health of the Universidad Peruana Cayetano Heredia, and one of the initiative's proponents, emphasized the importance of this regional collaboration: "The experience with COVID-19 demonstrated critical deficiencies in our public health infrastructure.
  • The LATAM CDC will serve as a fundamental pillar for prevention, preparedness, and rapid response to future health emergencies, thus strengthening our regional health sovereignty."
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .

Latino Physicians and Medical Professionals Gather to Talk Diversity Initiatives and the Future of Latino Healthcare

Retrieved on: 
Thursday, April 11, 2024
Obesity medicine, MACP, Health equity, AIDS, Health, White, Senior, Legislation, MPH, Physician, MBA, FACOG

The 30th Anniversary and Leadership Summit will feature over 30 keynote speakers from numerous facets of the healthcare industry, including advanced education, industry-leading research, rising medical residents, and practicing physicians.

Key Points: 
  • The 30th Anniversary and Leadership Summit will feature over 30 keynote speakers from numerous facets of the healthcare industry, including advanced education, industry-leading research, rising medical residents, and practicing physicians.
  • The "40 Under 40" campaign spotlights individuals who demonstrated extraordinary dedication, exemplary leadership, and profound contributions to advancing health equity.
  • These rising stars will be celebrated for their commitment to improving healthcare outcomes for Hispanic communities.
  • Selected honorees will be recognized at NHMA and NHHF's 30th Anniversary Gala on Saturday.

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

Retrieved on: 
Friday, April 26, 2024
Research, Pharmaceutical, Consumer, Infectious Diseases, Hospitals, Clinical Trials, Science, Baby, Maternity, Biotechnology, Women, AIDS, FDA, Health, University, Boxed warning, Gilead Sciences, Safety, PWH, Pregnancy, Pharmacokinetics, Woman, Food, CDC, Doctor of Philosophy, PCR, Tablet, Incidence, HIV-1, STR, HIV, DHHS, Associate, Plasma, National Medical Association

This update makes Biktarvy the only second-generation integrase strand transfer inhibitor (INSTI)-based single-tablet regimen (STR) with in-label clinical trial data and FDA approval in virologically suppressed adults who are pregnant.

Key Points: 
  • This update makes Biktarvy the only second-generation integrase strand transfer inhibitor (INSTI)-based single-tablet regimen (STR) with in-label clinical trial data and FDA approval in virologically suppressed adults who are pregnant.
  • Additionally, guidelines recommend continuing Biktarvy for PWH already on treatment who are virologically suppressed and tolerating treatment well who may become pregnant.
  • “This label update marks an important milestone for Biktarvy, reinforcing its efficacy profile for pregnant PWH, an often understudied and most vulnerable community in clinical research,” said Jared Baeten, MD, PhD, Vice President, HIV Clinical Development, Gilead Sciences.
  • “Not only is Biktarvy an alternative regimen for use in pregnancy, but people of childbearing potential can also remain on Biktarvy if they become pregnant.

AHF Withdraws Bid to Purchase Skid Row Housing Trust Buildings

Retrieved on: 
Thursday, April 25, 2024
Construction & Property, Urban Planning, Public Policy, Government, AIDS, State, Local, General Health, Health, Other Construction & Property, Residential Building & Real Estate, Sale, AHF, Trust, AIDS Healthcare Foundation, Housing

Today, AIDS Healthcare Foundation (AHF) notified the receiver for the Skid Row Housing Trust that AHF will not buy the six very troubled properties it intended to purchase for $27 million.

Key Points: 
  • Today, AIDS Healthcare Foundation (AHF) notified the receiver for the Skid Row Housing Trust that AHF will not buy the six very troubled properties it intended to purchase for $27 million.
  • During the escrow due diligence process, AHF learned that the six buildings would require $14 million to bring them up to a fully habitable state.
  • In addition, the operations of these properties are on track to lose $10 million in 2024.
  • Any buyer of these properties will find themselves in the same situation that led to the failure of Skid Row Housing Trust in short order unless a new model can be developed.

AHF Praises Colombia for Putting Lives Before Pharma Greed

Retrieved on: 
Friday, April 26, 2024
Medical Supplies, Hospitals, Public Policy, Government, Healthcare Reform, Biotechnology, AIDS, General Health, Pharmaceutical, Health, Other Policy Issues, Public, Hope, World Trade Organization, Partnership, Policy, ViiV Healthcare, Patient, AIDS Healthcare Foundation, Ministry, HIV, Social protection, AHF, Pharmaceutical industry

Thousands of lives and valuable health resources will be saved,” said AHF Director of Global Advocacy and Policy Guillermina Alaniz.

Key Points: 
  • Thousands of lives and valuable health resources will be saved,” said AHF Director of Global Advocacy and Policy Guillermina Alaniz.
  • “We salute the government of Colombia for putting the lives of people living with HIV ahead of pharma greed.
  • AHF has provided HIV screening services to more than 195,000 people in Colombia and HIV treatment to nearly 5,000 patients.
  • AHF Colombia currently serves 2,755 patients and operates clinics in Bogotá, Bucaramanga, Riohacha, Valledupar, Cartagena, and Cúcuta.

Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease

Retrieved on: 
Thursday, April 25, 2024
Biotechnology, Pharmaceutical, AIDS, Health, Medical Devices, Infectious Diseases, Philanthropy, Foundation, VOC, University, Organic compound, Atlas, University of Oxford, Volatile organic compound, Partnership, Disease, Imperial College London, Viral load, Bill, Melinda French Gates, Medicine, Infection, Diagnosis, HIV, Biomarker, TB, Tuberculosis, Medical imaging

The funding is comprised of a $5 million equity investment to advance Owlstone’s Breath Biopsy platform and $1.5 million in grant funding to develop breath-based diagnostics and identify breath biomarkers for tuberculosis (TB) and HIV.

Key Points: 
  • The funding is comprised of a $5 million equity investment to advance Owlstone’s Breath Biopsy platform and $1.5 million in grant funding to develop breath-based diagnostics and identify breath biomarkers for tuberculosis (TB) and HIV.
  • Owlstone, with support from the foundation, is interested in developing new cost-effective detection technologies for volatile organic compounds (VOCs) that could serve as markers of diseases that disproportionately affect the developing world.
  • Billy Boyle, co-founder and CEO at Owlstone Medical, said: “Early diagnosis is a critical determinant of health outcomes.
  • This investment by the Gates Foundation is testament to how Owlstone is uniquely positioned to transform infectious disease diagnosis through our Breath Biopsy platform.

The Antera Brand Back at the Summit of Light Alloy-wheel Producers

Retrieved on: 
Wednesday, April 24, 2024
Sports, Automotive, General Automotive, Vehicle Technology, Automotive Manufacturing, Manufacturing, Soccer, Tires & Rubber, Recreational Vehicles, Diamond, Personality, A105, System, Soka Gakkai, AIDS, Research, Number 10, Life, Culture, Tree, Instinct, A101, Art, Football, LAB, Philosophy, PV, Panther, Perseverance, Hand, Communication, HPE, Dalla, Aggression, Pinguini Tattici Nucleari, A107, Netflix, Eye, Broadway Cares/Equity Fights AIDS, ALS, Aluminium, Child, HIV, Milan Furniture Fair, Brazilian, Compromise, Nature, Hospital, Dream, Heart, Collection, Diodato, FEM, Engineering, Coppa Italia, Multimedia, Beauty, Autobiography, Made in Italy, Courage, Casting, Serie A, History, A103, Banca Ifis, ESG, Creativity, CO2, Ikeda, Growth, Corporate governance, Fashion design

The Antera brand makes its comeback on the world stage during the 2024 Milan Design Week with a new collection of light alloy wheels.

Key Points: 
  • The Antera brand makes its comeback on the world stage during the 2024 Milan Design Week with a new collection of light alloy wheels.
  • A premium made-in-Italy brand, Antera combines timeless design, cutting-edge technology, and the determination to overcome any obstacle.
  • The new Antera collection features five different models of various dimensions, from 19 inches to 24 inches, and seven finishes.
  • Today, on the occasion of the 2024 Milan Design Week, the prestigious Antera brand makes its comeback on the global scene with a new collection of light alloy wheels for the automotive industry.

Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development

Retrieved on: 
Wednesday, April 24, 2024
Health, Pharmaceutical, Technology, Artificial Intelligence, Oncology, Brain, Fox Chase Cancer Center, AIDS, Lung cancer, AI, Pancreatic cancer, Ambulatory care, Hematology, Machine learning, MD, Doctor of Philosophy, National Cancer Institute, Research, Ohio State University, Artificial intelligence, Disease, Science, Patient, NCI, Physician, Neoplasm, Central nervous system, Diagnosis, Drug development, Associate, Sanofi, Kishor, Medical director, AstraZeneca, Pharmaceutical industry

The series begins today, Wednesday, April 24, 2024, and is planned to be held on the last Wednesday of each month.

Key Points: 
  • The series begins today, Wednesday, April 24, 2024, and is planned to be held on the last Wednesday of each month.
  • Each webinar will feature a presentation from a Lantern collaborator, advisor, or researchers followed by a live Q&A.
  • These sessions provide a deep dive into the company’s research, collaborations, clinical trials and expected goals for the drug or AI development initiatives.
  • Igor Astsaturov, MD is a leading expert in pancreatic cancer collaborating with Lantern Pharma on the LP-184 clinical trial.

New Pandemic Agreement: Pharma Wins, Developing World Loses, says AHF Global Public Health Institute

Retrieved on: 
Wednesday, April 24, 2024
COVID-19, Infectious Diseases, Public Policy, Government, AIDS, Health, Pharmaceutical, General Health, Other Policy Issues, United Nations, Public, University, IHR, PABS, Language, WHO, Community of practice, Learning, Pandemic, World Health Organization, INB, Policy, Infection, Intergovernmental, Conference, Research, Vaccine, Hoarding, Literature, International Health Regulations, AIDS Healthcare Foundation, Panel, Global health, Secretariat, AHF, United Nations General Assembly, Lancet, Letter, Pharmaceutical industry

As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024 , Proposal for the WHO Pandemic Agreement.

Key Points: 
  • As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024 , Proposal for the WHO Pandemic Agreement.
  • In addition to the GPMB and the IPPPR, the Panel for a Global Public Health Convention and Spark Street Advisors have also emphasized the critical need for independent monitoring.
  • Empty handshakes in Geneva will not prevent another global health disaster, nor will it keep countries from trampling over each other when the next pandemic comes.
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .